BiopatchTM - a new concept in antimicrobial dressings for invasive devices-: . A. r -. TI t..4 .
1998
A randomised controlled trial (RCT) was conducted to assess the reduction in the rate of catheter-related infections associated with the BiopatchTM dressing (Johnson B Johnson Medical Inc., Arlington, Texas, USA) used for insertion-site management of central venous catheters (CVCs) placed in the intensive care unit. Patients having a CVC placed were randomly assigned to receive either a BiopatchTM keyhole dressing in addition to the occlusive Opsite N 3000TM (Smith and Nephew Medical Ltd, Hull, UK) (experimental group) or the Opsite N 3000TM alone (control group).
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
6
References
0
Citations
NaN
KQI